Leave a comment
July 1, 2014 by dailybolusoflr
Medical Minute from Darren Mareiniss, MD JD
Vasopressors in shock: SOAP II Study Data and the 2012 Surviving Sepsis Guidelines
SOAP II Study Comparing Norepinephrine versus Dopamine for All Causes of Sepsis
Design: Multicenter, randomized trial where patients with shock received either dopamine or norepinephrine as first line agents to maintain BP. When BP could not be maintained on either 20 ug/kg/min dopamine or .19 ug/kg/min Norepinephrine, open-label norepinephrine, vasopressin or epinephrine was used.
Results: 1679 patients with 858 in the dopamine group and 821 in the norepinephrine group. There was no mortality difference at 28 days (52.5% in dopamine group and 48.5% in the norepinephrine group). More arrhythmia in the dopamine group – 207 (24.1%) versus 102 (12.4%), P <0.001. A subgroup analysis showed that dopamine resulted in a higher 28 day mortality in patients with cardiogenic shock, P=0.03.
Conclusion: Dopamine increased arrhythmia in patients compared to norepinephrine. With respect to cardiogenic shock, dopamine had significantly increased 28 day mortality.
Meta-analysis by De Backer et al – shows a modest increased relative risk of mortality for use of Dopamine versus Norepinephrine. RR of death 1.12; 95% CI, 1.01-1.2; P=0.035.
Bottom Line– Dopamine appears to be associated with increased mortality and arrhythmia when used as a first line agent in shock. In particular, dopamine appears to increase mortality in cardiogenic shock and should not be used for this pathology
2012 Surviving Sepsis Guidelines for Vasopressors
- After 30 ml/kg of crystalloid – use vasopressors to keep MAP > 65 mm Hg
- First line agent – Norepinephrine
- Second line – add Vasopressin at .03 u/min – do not use .04 u/min unless for salvage
- Second line – may add or substitute Epinephrine for Norepinephrine
- Third line agents – Dopamine is only recommended for select patients at low risk for tachyarrhythmia and absolute or relative bradycardia
- Fourth line agent – Phenylephrine is not recommend in septic shock except – However, can be given when: (1) cardiac output is known to be high and BP is low; (2) Norepinephrine is associated with serious arrhythmia; or (3) as salvage therapy when inotrope/vasopressors and low dose Vasopressin has failed.
- DeDe Backer D, Biston P, Devriendt J et al. Comparison of Dopamine and Norepinephrine in the Treatment of Shock. N Engl J Med. 2010;362(9):779-789.
- De Backer D, Aldecoa C, Njimi H et al. Dopamine versus norepinephrine in the treatment of septic shock: A meta-analysis. Crit Care Med 2012;40(3):725-730.
- Dellinger RP, Levy MM, Rhodes A et al. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock. Intensive Care Med 2013; 39:165-228.